Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment

Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 3

Abstract

Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and PSMA-directed radioligand therapy (RLT) with Lutetium-177 (Lu-177) PSMA is promising systemic modality, which involves the delivery of targeted radiation therapy in the form of β-particles to sites of tumour tissue. Although, Lu-177 PSMA RLT has been recently introduced for castration-resistant metastatic prostate cancer (CRMPC), has continuously increasing interest and use in many centers. Therapy is well tolerated with relatively few side effects and has a positive effect on overall survival and quality of life. The purpose of this guideline is to assist nuclear medicine specialists in evaluating and managing patients with RCMPC for whom RLT using Lu-177 PSMA as an “unproven intervention in clinical practice”, in accordance with the best currently available knowledge.

Authors and Affiliations

İlknur Ak Sivrikoz, Gülin Uçmak, Gamze Kaya Çapa, Emre Demirci, Nalan Alan Selçuk, Cüneyt Türkmen, Umut Elboğa, Levent Kabasakal

Keywords

Related Articles

Good Radiopharmacy Practices In Magistral (or Inhouse or Smallscale) Produced Radiopharmaceuticals

Radiopharmaceuticals differ from normal medicines in that they have a short half-life. Due to the rapid decay, they must be prepared shortly before their clinical use and comprehensive quality control of the final produc...

Non-ultrasonographic and Non-radioiodine Imaging Techniques in Thyroid Cancer

Ultrasonography is the most commonly used and most effective imaging modality in thyroid cancer imaging. It is the most successful method for evaluating primary tumor and local disease. I-131 scintigraphy is also a usefu...

The Role of Nuclear Medicine in Pediatric Hydronephrosis

Nuclear medicine studies are non-invasive, simple, functional diagnostic investigations that can be used in all ages of childhood even in the neonatal period. While dynamic renal scintigraphy has been a well-established...

Imaging Guideline in Pediatric Neuroblastoma Patients

The aim of this procedure guideline is the standardization of I-123 metaiodobenzylguanidine scintigraphy, F-18 fluorodeoxyglucose, F-18 fluoropheniylalanine, Ga-68 DOTA peptide positron emission tomography/computerized t...

Guideline for the Treatment of Liver Cancer with Y-90 Radiomicrosphere

Yttrium-90 microsphere therapy, which has become more common in recent years, offers an effective and safe radionuclide treatment option in the treatment of primary and metastatic liver tumors. The success of the treatme...

Download PDF file
  • EP ID EP691580
  • DOI 10.4274/nts.galenos.2020.0031
  • Views 111
  • Downloads 0

How To Cite

İlknur Ak Sivrikoz, Gülin Uçmak, Gamze Kaya Çapa, Emre Demirci, Nalan Alan Selçuk, Cüneyt Türkmen, Umut Elboğa, Levent Kabasakal (2020). Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment. Nuclear Medicine Seminars, 6(3), -. https://europub.co.uk/articles/-A-691580